Dispersyn Gerrit
- SEC CIK
- 0001704417
No open-market purchases or sales filed in the past year.
Current role at each company
- PHIO Phio Pharmaceuticals Corp.President & CEOas of Mar 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dispersyn Gerrit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Dispersyn GerritPresident & CEO | PPurchaseCommon stock, $0.0001 par value | +6.00K | $1.63 | +$9.78K | +6.7%95.3K after |